- Home
- EDAP vs BYSI Comparison
EDAP vs BYSI Comparison
Compare EDAP & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDAP
- BYSI
- Stock Information
- Founded
- EDAP 1979
- BYSI 2010
- Country
- EDAP France
- BYSI United States
- Employees
- EDAP N/A
- BYSI N/A
- Industry
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- EDAP Health Care
- BYSI Health Care
- Exchange
- EDAP Nasdaq
- BYSI Nasdaq
- Market Cap
- EDAP 88.7M
- BYSI 72.1M
- IPO Year
- EDAP 1997
- BYSI 2017
- Fundamental
- Price
- EDAP $2.15
- BYSI $1.44
- Analyst Decision
- EDAP Strong Buy
- BYSI
- Analyst Count
- EDAP 2
- BYSI 0
- Target Price
- EDAP $11.75
- BYSI N/A
- AVG Volume (30 Days)
- EDAP 180.2K
- BYSI 14.0K
- Earning Date
- EDAP 03-27-2025
- BYSI 01-01-0001
- Dividend Yield
- EDAP N/A
- BYSI N/A
- EPS Growth
- EDAP N/A
- BYSI N/A
- EPS
- EDAP N/A
- BYSI N/A
- Revenue
- EDAP $66,378,507.00
- BYSI N/A
- Revenue This Year
- EDAP $16.46
- BYSI N/A
- Revenue Next Year
- EDAP $14.30
- BYSI N/A
- P/E Ratio
- EDAP N/A
- BYSI N/A
- Revenue Growth
- EDAP 6.11
- BYSI N/A
- 52 Week Low
- EDAP $1.96
- BYSI $1.40
- 52 Week High
- EDAP $8.50
- BYSI $3.63
- Technical
- Relative Strength Index (RSI)
- EDAP 39.79
- BYSI 29.84
- Support Level
- EDAP $1.96
- BYSI $1.46
- Resistance Level
- EDAP $2.57
- BYSI $1.65
- Average True Range (ATR)
- EDAP 0.24
- BYSI 0.11
- MACD
- EDAP -0.02
- BYSI -0.03
- Stochastic Oscillator
- EDAP 31.15
- BYSI 9.09
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.